Impotence/Erectile Dysfunction (cont.)
Medical Author:
Stephen W Leslie, MD, FACS
Coauthor:
Stanley A Brosman, MD
Medical Editor:
Joseph A Salomone III, MD
Medical Editor:
Francisco Talavera, PharmD, PhD
Medical Editor:
Richard Harrigan, MD
IN THIS ARTICLE
References1. Althof SE, Corty EW, Levine SB, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. Apr 1999;53(4):793-9. [Medline]. 2. American Foundation for Urologic Disease. American Foundation for Urologic Disease. Available at http://www.afud.org/. 3. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. Jan 1995;75(1):191-236. [Medline]. 4. Cheitlin MD, Hutter AM Jr, Brindis RG, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol. Jan 1999;33(1):273-82. [Medline]. 5. FDA Center for Drug Evaluation and Research. FDA Center for Drug Evaluation and Research. Available at http://www.fda.gov/cder/. 6. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. Jan 1994;151(1):54-61. [Medline]. 7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. Feb 10 1999;281(6):537-44. [Medline]. 8. Leslie S. Impotence: current diagnosis and treatment. 1997. 9. National Kidney and Urologic Diseases Clearinghouse. National Kidney and Urologic Diseases Clearinghouse. Available at http://kidney.niddk.nih.gov/. 10. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. Jul 7 1993;270(1):83-90. [Medline]. 11. Pfizer Inc. Pfizer Inc. Available at http://www.pfizer.com/pfizer/main.jsp. 12. Segraves RT, Bari M, Segraves K, Spirnak P. Effect of apomorphine on penile tumescence in men with psychogenic impotence. J Urol. Jun 1991;145(6):1174-5. [Medline]. 13. The European Alprostadil Study Group. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. Br J Urol. Oct 1998;82(4):538-43. [Medline]. 14. The Process of Care Consensus Panel. The process of care model for evaluation and treatment of erectile dysfunction. Int J Impot Res. Apr 1999;11(2):59-70; discussion 70-4. [Medline]. Next Page: Must Read Articles Related to Impotence/Erectile Dysfunction
Erectile Dysfunction FAQs
Erectile dysfunction (or ED), also called male impotence, describes a man's inability to achieve and maintain an erection of his penis sufficient for mutually s...learn more >>
|
Sex & Relationships
Get tips to boost your love life.
From WebMD
Men's Health Resources
Featured Centers
Health Solutions From Our Sponsors
Read What Your Physician is Reading on Medscape
Erectile Dysfuncton »
Sexual health and function are important determinants of quality of life.
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick, easy,
pill identification
Find a Local Pharmacy
- including 24 hour, pharmacies



